Status
Conditions
Treatments
About
This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.
Full description
A direct comparison between usual care and ECLS treatment is difficult. Alternatively we compare predicted mortality for every patient based on validated scoring systems at the initiation of ECLS treatment with the actual outcome, so every patient is his own control.
Primary outcome is HRQoL assessed with the EQ-5D questionnaire at 1 year. Healthcare costs and costs from a societal perspective are prospectively measured.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Wim Dieperink, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal